Impact of preoperative locoregional therapy on recurrence and patient survival following liver transplantation for hepatocellular carcinoma: a meta-analysis

References

• Colombo M. Screening and diagnosis of hepatocellular carcinoma. Liver Int. 2009;29:143–147.
   PubMed Web of Science ®Google Scholar
• Taura K, Ikai I, Hatano E, et al. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients. Surgery. 2007;142:685–694.
   PubMed Web of Science ®Google Scholar
• Cherqui D, Laurent A, Mocellin N, et al. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg. 2009;250:738–746.
   PubMed Web of Science ®Google Scholar
• Schwartz M, Roayaie S, Uva P. Treatment of HCC in patients awaiting liver transplantation. Am J Transplant. 2007;7:1875–1881.
   PubMed Web of Science ®Google Scholar
• Lao OB, Weissman J, Perkins JD. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation. Clin Transplant. 2009; 23:874–881.
   PubMed Web of Science ®Google Scholar
• DuBay DA, Sandroussi C, Kachura JR, et al. Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. HPB (Oxford). 2011;13:24–32.
   PubMed Web of Science ®Google Scholar
• Athanasiou T, Al-Ruzzeh S, Kumar P, et al. Off-pump myocardial revascularization is associated with less incidence of stroke in elderly patients. Ann Thorac Surg. 2004;77:745–753.
   PubMed Web of Science ®Google Scholar
• Taggart DP, D'Amico R, Altman DG. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet. 2001;358:870–875.
   PubMed Web of Science ®Google Scholar
• Guyot P, Ades AE, Ouwens MJ, et al. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan–Meier survival curves. BMC Med Res Methodol. 2012;12:9.
   PubMed Web of Science ®Google Scholar
• Moher D, Cook DJ, Eastwood S, et al. [Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM Statement]. Rev Esp Salud Publica. 2000;74:107–118.
   PubMedGoogle Scholar
• Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–2012.
   PubMed Web of Science ®Google Scholar
• Stockland AH, Walser EM, Paz-Fumagalli R, et al. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate. Cardiovasc Intervent Radiol. 2007;30:888–893.
   PubMed Web of Science ®Google Scholar
• Bharat A, Brown DB, Crippin JS, et al. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg. 2006;203:411–420.
   PubMed Web of Science ®Google Scholar
• Seehofer D, Nebrig M, Denecke T, et al. Impact of neoadjuvant TACE on tumor recurrence and patient survival after liver transplantation for HCC. Transplantation. 2010;90:2613.
   Google Scholar
• Yao FY, Kinkhabwala M, LaBerge JM, et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant. 2005;5:795–804.
   PubMed Web of Science ®Google Scholar
• Kim JM, Kwon Ch, Joh JW, et al. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria. Transplant Proc. 2012;44:403–408.
   PubMed Web of Science ®Google Scholar
• Porrett PM, Peterman H, Rosen M, et al. Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl. 2006;12:665–673.
   PubMed Web of Science ®Google Scholar
• Kim PT, Onaca N, Chinnakotla S, et al. Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation. Clin Transplant. 2013;27:311–318.
   PubMed Web of Science ®Google Scholar
• Eswaran SL, Pierce K, Weaver F, et al. Transarterial chemoembolization for HCC in patients with extensive liver transplantation waiting times. Angiology. 2012;63:206–212.
   PubMed Web of Science ®Google Scholar
• Decaens T, Roudot- Thoraval F, Bresson-Hadni S, et al. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl. 2005;11:767–775.
   PubMed Web of Science ®Google Scholar
• Cheng YF, Huang TL, Chen TY, et al. Impact of pre-operative transarterial embolization on the treatment of hepatocellular carcinoma with liver transplantation. World J Gastroenterol. 2005;11:1433–1438.
   PubMed Web of Science ®Google Scholar
• Heckman JT, Devera MB, Marsh JW, et al. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann Surg Oncol. 2008;15:3169–3177.
   PubMed Web of Science ®Google Scholar
• Johnson EW, Holck PS, Levy AE, et al. The role of tumor ablation in bridging patients to liver transplantation. Arch Surg. 2004;139:825–829. discussion 829–830.
   PubMedGoogle Scholar
• Graziadei IW, Sandmuller H, Waldenberger P, et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl. 2003;9:557–563.
   PubMed Web of Science ®Google Scholar
• Yao FY, Bass NM, Nikolai B, et al. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl. 2003;9:684–692.
   PubMed Web of Science ®Google Scholar
• Yan S, Xu D, Sun B. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis. Dig Dis Sci. 2013;58:2107–2113.
   PubMed Web of Science ®Google Scholar
• Ni JY, Liu SS, Xu LF, et al. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol. 2013;19:3872–3882.
   PubMed Web of Science ®Google Scholar
• Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg. 1997;226:688–701. discussion 701–703.
   PubMed Web of Science ®Google Scholar